Emily S Jungheim1, Anthony O Odibo. 1. Department of Obstetrics and Gynecology, Washington University, St. Louis, Missouri 63108, USA. jungheime@wudosis.wustl.edu
Abstract
OBJECTIVE: To compare different oral ovulation induction agents in treating infertile women with polycystic ovary syndrome (PCOS). DESIGN: Decision-analytic model comparing three treatment strategies using probability estimates derived from literature review and sensitivity analyses performed on the baseline assumptions. SETTING: Outpatient reproductive medicine and gynecology practices. PATIENT(S): Infertile women with PCOS. INTERVENTION(S): Metformin, clomiphene citrate, or metformin with clomiphene citrate. MAIN OUTCOME MEASURE(S): Live birth. RESULT(S): Within the baseline assumptions, combination therapy with metformin and clomiphene citrate was the preferred therapy for achieving live birth in women with PCOS. Sensitivity analysis revealed the model to be robust over a wide range of probabilities. CONCLUSION(S): Combination therapy with metformin and clomiphene citrate should be considered as first-line treatment for infertile women with PCOS.
OBJECTIVE: To compare different oral ovulation induction agents in treating infertilewomen with polycystic ovary syndrome (PCOS). DESIGN: Decision-analytic model comparing three treatment strategies using probability estimates derived from literature review and sensitivity analyses performed on the baseline assumptions. SETTING:Outpatient reproductive medicine and gynecology practices. PATIENT(S): Infertilewomen with PCOS. INTERVENTION(S): Metformin, clomiphene citrate, or metformin with clomiphene citrate. MAIN OUTCOME MEASURE(S): Live birth. RESULT(S): Within the baseline assumptions, combination therapy with metformin and clomiphene citrate was the preferred therapy for achieving live birth in women with PCOS. Sensitivity analysis revealed the model to be robust over a wide range of probabilities. CONCLUSION(S): Combination therapy with metformin and clomiphene citrate should be considered as first-line treatment for infertilewomen with PCOS.
Authors: D A Ehrmann; M K Cavaghan; J Imperial; J Sturis; R L Rosenfield; K S Polonsky Journal: J Clin Endocrinol Metab Date: 1997-02 Impact factor: 5.958
Authors: Evan R Myers; Susan G Silva; Gail Hafley; Allen R Kunselman; John E Nestler; Richard S Legro Journal: Contemp Clin Trials Date: 2005-06 Impact factor: 2.226
Authors: Richard Fleming; Zoe E Hopkinson; A Michael Wallace; Ian A Greer; Naveed Sattar Journal: J Clin Endocrinol Metab Date: 2002-02 Impact factor: 5.958
Authors: Kerri L Marquard; Sahar M Stephens; Emily S Jungheim; Valerie S Ratts; Randall R Odem; Susan Lanzendorf; Kelle H Moley Journal: Fertil Steril Date: 2010-11-11 Impact factor: 7.329
Authors: Elizabeth E Puscheck; Alan Bolnick; Awoniyi Awonuga; Yu Yang; Mohammed Abdulhasan; Quanwen Li; Eric Secor; Erica Louden; Maik Hüttemann; Daniel A Rappolee Journal: J Assist Reprod Genet Date: 2018-06-07 Impact factor: 3.412
Authors: Alan Bolnick; Mohammed Abdulhasan; Brian Kilburn; Yufen Xie; Mindie Howard; Paul Andresen; Alexandra M Shamir; Jing Dai; Elizabeth E Puscheck; Daniel A Rappolee Journal: J Assist Reprod Genet Date: 2016-05-26 Impact factor: 3.412
Authors: Alan Bolnick; Mohammed Abdulhasan; Brian Kilburn; Yufen Xie; Mindie Howard; Paul Andresen; Alexandra M Shamir; Jing Dai; Elizabeth E Puscheck; Eric Secor; Daniel A Rappolee Journal: J Assist Reprod Genet Date: 2017-09-15 Impact factor: 3.412
Authors: Kelly Kuo; Victoria H J Roberts; Jessica Gaffney; Diana L Takahashi; Terry Morgan; Jamie O Lo; Richard L Stouffer; Antonio E Frias Journal: Endocrinology Date: 2019-08-01 Impact factor: 4.736
Authors: Leopoldo O Tso; Michael F Costello; Luiz Eduardo T Albuquerque; Régis B Andriolo; Cristiane R Macedo Journal: Cochrane Database Syst Rev Date: 2014-11-18